JOPIC
Journal of Pulmonology and Intensive Care

The JoPIC is an independent-unbiased, peer-reviewed, and open-access journal of current national and international issues and reviews for original clinical and experimental research, interesting case reports, surgical techniques, differential diagnoses, editorial opinions, letters to the editor, and educational papers in pulmonology, thoracic surgery, occupational diseases, allergology, and intensive care medicine.

eISSN: 2980-0803
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Review
Current approaches to the diagnosis, treatment, and prognosis of sepsis
Abstract
Sepsis is a critical clinical condition characterized by organ dysfunction resulting from an uncontrolled host response to infection and is associated with a high risk of mortality. Its incidence is increasing due to aging populations, immunosuppression, and resistant pathogens. Although bacteria are the most common causative agents, viral pathogens such as SARS-CoV-2 have also emerged as important contributors. Advanced age, comorbidities, immune deficiencies, and nosocomial infections are the main risk factors. Diagnosis is established through a combined assessment of clinical, laboratory, radiological, and microbiological findings. Early fluid resuscitation, oxygen support, and appropriate empirical antibiotic therapy are crucial in reducing mortality. Timely initiation of appropriate treatment improves survival and plays a life-saving role.

Keywords : Sepsis, septic shock, organ dysfunction, MODS

Download Article


1. Singer M, Deutschman CS, Seymour CW, et al. The third ınternational consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801-810. doi:10.1001/jama.2016.0287
2. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23(10):1638-1652. doi:10.1097/ 00003246-199510000-00007
3. Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063-e1143. doi:10.1097/CCM. 0000000000005337
4. Qiu X, Lei YP, Zhou RX. SIRS, SOFA, qSOFA, and NEWS in the diagnosis of sepsis and prediction of adverse outcomes: a systematic review and meta-analysis. Expert Rev Anti Infect Ther. 2023;21(8):891-900. doi:10.1080/14787210.2023.2237192
5. Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):762-774. doi:10.1001/jama. 2016.0288
6. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the united states from 1979 through 2000. N Engl J Med. 2003; 348(16):1546-1554. doi:10.1056/NEJMoa022139
7. Prescott HC, Harrison DA, Rowan KM, Shankar-Hari M, Wunsch H. Temporal trends in mortality of critically ill patients with sepsis in the united kingdom, 1988-2019. Am J Respir Crit Care Med. 2024;209(5): 507-516. doi:10.1164/rccm.202309-1636OC
8. Li A, Ling L, Qin H et al. Epidemiology, management, and outcomes of sepsis in icus among countries of differing national wealth across asia. Am J Respir Crit Care Med. 2022;206(9):1107-1116. doi:10.1164/rccm. 202112-2743OC
9. Danai PA, Sinha S, Moss M, Haber MJ, Martin GS. Seasonal variation in the epidemiology of sepsis. Crit Care Med. 200735(2):410-415. doi:10. 1097/01.CCM.0000253405.17038.43
10. Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA. 2014;311(13):1308-1316. doi:10.1001/jama.2014.2637
11. Gupta S, Sakhuja A, Kumar G, McGrath E, Nanchal RS, Kashani KB. Culture- negative severe sepsis: nationwide trends and outcomes. Chest. 2016;150(6):1251-1259. doi:10.1016/j.chest.2016.08.1460
12. Vincent JL, Bihari DJ, Suter PM et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the european prevalence of infection in intensive care (EPIC) study. EPIC international advisory committee. JAMA. 1995;274(8):639-644.
13. Jones GR, Lowes JA. The systemic inflammatory response syndrome as a predictor of bacteraemia and outcome from sepsis. QJM. 1996;89(7): 515-522. doi:10.1093/qjmed/89.7.515
14. Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med. 2006;34(1):15-21. doi:10.1097/01.ccm.0000194535.82812.ba
15. Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis. 2006; 6(7):438-446. doi:10.1016/S1473-3099(06)70523-0
16. Williams MD, Braun LA, Cooper LM et al. Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit Care. 2004;8(5):R291-298. doi:10.1186/cc2893
17. Prescott HC, Dickson RP, Rogers MA, Langa KM, Iwashyna TJ. Hospitalization type and subsequent severe sepsis. Am J Respir Crit Care Med. 2015;192(5):581-588. doi:10.1164/rccm.201503-0483OC
18. Netea MG, van der Meer JW. Immunodeficiency and genetic defects of pattern- recognition receptors. N Engl J Med. 2011;364(1):60-70. doi:10. 1056/NEJMra1001976
19. Haas SA, Lange T, Saugel B, et al. Severe hyperlactatemia, lactate clearance and mortality in unselected critically ill patients. Intensive Care Med. 2016;42(2):202-210. doi:10.1007/s00134-015-4127-0
20. Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378(9): 809-818. doi:10.1056/NEJMoa1705716
21. Brun-Buisson C, Doyon F, Carlet J. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French bacteremia-sepsis study group. Am J Respir Crit Care Med. 1996;154(31):617-624. doi:10.1164/ajrccm.154.3.8810595
22. Beran A, Altorok N, Srour O, et al. Balanced crystalloids versus normal saline in adults with sepsis: a comprehensive systematic review and meta-analysis. J Clin Med. 2022,;11(7):1971. doi:10.3390/jcm11071971
23. Mouncey PR, Osborn TM, Power GS, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372(14):1301-1311. doi:10.1056/NEJMoa1500896
24. Caironi P, Tognoni G, Masson S, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370(15):1412-1421. doi:10.1056/NEJMoa1305727
25. De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9): 779-789. doi:10.1056/NEJMoa0907118
26. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin- resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352(14):1436-1444. doi:10.1056/NEJMoa043252
27. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303-1310. doi:10.1097/00003246-200107000-00002
28. Tolsma V, Schwebel C, Azoulay E, et al. Sepsis severe or septic shock: outcome according to immune status and immunodeficiency profile. Chest. 2014;146(5):1205-1213. doi:10.1378/chest.13-2618
29. Klein Klouwenberg PM, Frencken JF, Kuipers S, et al. Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis. A cohort study. Am J Respir Crit Care Med. 2017; 195(2):205-211. doi:10.1164/rccm.201603-0618OC
30. Seymour CW, Kennedy JN, Wang S, et al. Derivation, validation, and potential treatment ımplications of novel clinical phenotypes for sepsis. JAMA. 2019;321(20):2003-2017. doi:10.1001/jama.2019.5791
31. Zahar JR, Timsit JF, Garrouste-Orgeas M, et al. Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality. Crit Care Med. 2011;39(8):1886-1895. doi:10.1097/CCM.0b013e31821b827c
32. Ou SM, Chu H, Chao PW, et al. Long-term mortality and major adverse cardiovascular events in sepsis survivors. A nationwide population-based study. Am J Respir Crit Care Med. 2016;194(2):209-217. doi:10.1164/rccm.201510-2023OC
Article available in :
Volume 4, Issue 1, 2026
Page : 23-26
https://doi.org/10.51271/JOPIC-0074
Article Information
Received : 21 Ağu 2025
Accepted : 09 Kas 2025
Published : 12 Şub 2026
Corresponding Author :

Maşide Arı: Department of Pulmonology, Ankara Atatürk Sanatorium Training and Research Hospital, Ankara, Turkiye

[email protected]
Citation : Arı M. Current approaches to the diagnosis, treatment, and prognosis of sepsis. J Pulmonol Intens Care. 2026;4(1):23-26.

Read: 73
Download : 59
Cited: 0
_Footer